08.06.2012 • News

Laura L. Parks appointed President and Business Unit Director at DSM Pharmaceutical Products

Laura L. Parks, Ph.D., currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM has been appointed President and Business Unit Director of DSM Pharmaceuticals as of June 1, 2012.

Laura will continue to report to Alexander R. Wessels, President and Chief Executive Officer of DSM Pharmaceutical Products, as a member of the Management Team.

 

Dr. Parks joined DSM in 2008. Prior to DSM, she was with World Financial Group, and Solae (a Division of DuPont), a public company of over 10,000 employees, as Vice President of Sales.

 

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read